Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line

Prostate

Volumn 34, Issue 4, 1998, Pages 275-282

  Bae, Victoria L ^a   Jackson Cook, Colleen K ^a   Maygarden, Susan J ^b   Plymate, Steven R ^c   Chen, Juza ^d   Ware, Joy L ^a,e  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d TEL AVIV UNIVERSITY   (Israel)

^e VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Human prostate cancer; Metastasis; Neoplastic progression; SV40 large T antigen immortalization

Indexed keywords

ANDROGEN RECEPTOR; VIRUS LARGE T ANTIGEN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CYTOGENETICS; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; KARYOTYPE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; SIMIAN VIRUS 40; Y CHROMOSOME;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; EPITHELIAL CELLS; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM METASTASIS; PROSTATE; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0031944186     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980301)34:4<275::AID-PROS5>3.0.CO;2-G     Document Type: Article

References (31)

1. Sakr WA, Macoska JA, Benson P, Grignon DJ, Wolman SR, Pontes JE, Crissman JD: Allelic loss in locally metastatic, multi-sampled prostate cancer. Cancer Res 1994;54:3273-3277.
2. Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs WB: Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 1990;87;8751-8755.
3. Cher ML, Ito T, Weidner N, Carroll PR, Jensen RH: Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH). J Urol 1995;153:249-254.
4. Visakorpi T, Kallioniemi AH, Syvanen AC, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi OP: Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 1995;55:342-347.
5. Qian J, Bostwick DG, Takahashi S, Borell TJ, Herath J F, Lieber MM, Jenkins RB: Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res 1995;55:5408-5414.
6. Kallioniemi OP, Visakorpi T: Genetic basis and clonal evolution of human prostate cancer. Adv Cancer Res 1996;68:225-255.
7. Ware JL, Paulson DF, Mickey GH, Webb KS: Spontaneous metastasis of cells of the human prostate carcinoma cell line PC-3 in athymic nude mice. J Urol 1982;128:1064-1067.
8. Kozlowski JM, Fidler IJ, Campbell D, Xu ZL, Kaighn ME, Hart IR: Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res 1984;44:3522-3529.
9. Ware JL, Lieberman AP, Webb KS, Vollmer RT: Factors influencing phenotypic diversity of human prostate carcinoma cells metastasizing in athymic nude mice. Exp Cell Biol 1985;53:163-169.
10. Wang M, Stearns ME: Isolation and characterization of PC-3 human prostatic tumor sublines which preferentially metastasize to select organs in SCID mice. Differentiation 1991;48:115-125.
11. Stephenson RA, Dinney CP, Gohji K, Ordonez NG, Killion JJ, Fidler IJ: Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J Natl Cancer Inst 1992;84: 951-957.
12. Thalman GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, Hopwood VL, Pathak S, von Eschenbach AC, Chung LW: Androgen independent cancer progression and bone metastasis in the LN-CaP model of human prostate cancer. Cancer Res 1994;54:2577-2581.
13. Kaighn ME, Reddel RR, Lechner JF, Peehl DM, Camalier RF, Brash DE, Saffiotti U, Harris CC: Transformation of human neonatal prostate epithelial cells by strontium phosphate transfection with a plasmid containing SV40 early region genes. Cancer Res 1989;49:3050-3056.
14. Cussenot O, Berthon P, Berger R, Mowszowicz I, Faille A, Hojman F, Teillac, P, LeDuc A, Clavo F: Immortalization of human adult normal prostatic epithelial cells by liposomes containing large T-SV40 gene. J Urol 1991;146:881-886.
15. Hayward SS, Dahiya R, Cunha GR, Bartek J, Deshpande N, Narayan P: Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In Vitro Cell Dev Biol Anim 1995;31:14-24.
16. Lee M, Garkovenko E, Yun J, Weijerman PC, Peehl DM, Chen L, Rhim JS: Characterization of adult human prostatic epithelial cells immortalized by polybrene-induced DNA transfection with a plasmid containing an origin-defective SV40 genome. Int J Oncol 1994;4:821-830.
17. Rhim JS, Webber MM, Bello D, Lee MS, Arnstein P, Chen LS, Jay G: Stepwise immortalization and transformation of adult human prostate epithelial cells by a combination of HPV-18 and v-Ki-ras. Proc Natl Acad Sci USA 1994;91:11874-11878.
18. Weijerman PC, Konig JJ, Wong ST, Niesters HG, Peehl DM: Lipofectin mediated immortalization of human prostatic epithelial cells of normal and malignant origin using human papillomavirus type 18 DNA. Cancer Res 1994;54:5579-5583.
19. Bae VL, Jackson-Cook CK, Brothman AR, Maygarden SJ, Ware JL: Tumorigenicity of SV40 T antigen immortalized human prostate epithelial cells: Association with decreased epidermal growth factor receptor (EGFR) expression. Int J Cancer 1994;58: 721-729.
20. Webber MM, Bello D, Kleinman HK, Wartinger DD, Williams DE, Rhim JS: Prostate specific antigen and androgen receptor induction of an immortalized adult human prostatic epithelial cell line. Carcinogenesis 1996;8:1641-1646.
21. Kuettel MR, Thraves PJ, Jung M, Varghese SP, Prasad SC, Rhim JS, Dritschilo A: Radiation-induced neoplastic transformation of human prostate epithelial cells. Cancer Res 1996;56:5-10.
22. Barch M: Giemsa-banding technique using trypsin (GTG). In "ACT Cytogenetics Laboratory Manual," 2nd Ed. New York: Raven Press, 1991, pp 221-222.
23. Jackson-Cook C, Bae V, Edelman W, Brothman A, Ware J: Cytogenetic characterization of the human prostate cancer cell line P69SV40T and its novel tumorigenic sublines M2182 and M15. Cancer Genet Cytogenet 1996;87:14-23.
24. Mansouri A, Spurr N, Goodfellow PN, Kemler R: Characterization and chromosomal localization of the gene encoding the human cell adhesion molecule uvomorulin. Differentiation 1988;38:67-71.
25. Koyama K, Emi M, Nakamura Y: The cell adhesion regulator (CAR) gene, TaqI and insertion/deletion polymorphisms, and regional assignment to the peritelomeric region of 16q by linkage analysis. Genomics 1993;16:264-265.
26. Rav R, Miller DM: Cloning and characterization of a human c-myc promoter binding protein. Mol Cell Biol 1991;11:2154-2161.
27. Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM: Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA 1082;79:7824-7827.
28. Jackson-Cook CK, Bae V, Astbury C, Ware JL: A new tumorigenic human prostate cancer cell line (M2205) with c-myc amplification due to jumping translocations. Am J Hum Genet 1995;A302 (abst).
29. Ashkankty IM, Ferreira-Gonzalez A, Ware JL, Garrett C: c-myc amplification and expression among human prostate cancer cell lines of different malignant potential. Proc Am Assoc Cancer Res 1996;37:236A (abst).
30. 0) prostate carcinoma. Clin Cancer Res 1996;2:137-145.
31. Gingrich JR, Barrios RJ, Morton RA, Boyce BF, DeMayo FJ, Finegold MJ, Angelopoulou R, Rosen JM, Greenberg NM: Metastatic prostate cancer in a transgenic mouse. Cancer Res 1996; 56:4096-4102.